Revance(RVNC) - 2019 Q4 - Earnings Call Transcript

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2019 Results Earnings Conference Call February 24, 2020 4:30 AM ET Company Participants Jeanie Herbert - Senior Director of Investor Relations and Corporate Communications Mark Foley - President, Chief Executive Officer Dustin Sjuts - Chief Commercial Officer of Aesthetics & Therapeutics Toby Schilke - Chief Financial Officer Abhay Joshi - Chief Operating Officer, President of R&D and Product Operations Conference Call Participants Annabel Samimy - Stifel Ken Cacc ...